Read today's eNewspaper

Sexually Transmitted Diseases

Drug to protect against HIV not reaching those most at risk

Drug to protect against HIV not reaching those most at risk

Many of the people most at risk of contracting HIV in Baltimore know nothing about a drug that is 92 percent effective in preventing the infection, according to new research from the Johns Hopkins Bloomberg School of Public Health.

Only about 40 percent of gay and bisexual men with no HIV diagnosis had heard of pre-exposure prophylaxis medication, or PrEP, according to findings published this month in the American Journal of Preventive Medicine.

Even men who had recently visited a doctor or been tested for a sexually transmitted disease were not told about the PrEP drug, a daily pill recommended by the Centers for Disease Control and Prevention for people at high risk of...

50°